BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7203 related articles for article (PubMed ID: 25610726)

  • 1. An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy.
    Michaud M; Xie X; Bravo-San Pedro JM; Zitvogel L; White E; Kroemer G
    Oncoimmunology; 2014; 3(7):e944047. PubMed ID: 25610726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy.
    Castoldi F; Vacchelli E; Zitvogel L; Maiuri MC; Pietrocola F; Kroemer G
    Oncoimmunology; 2019; 8(1):e1498285. PubMed ID: 30546941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death.
    Martins I; Michaud M; Sukkurwala AQ; Adjemian S; Ma Y; Shen S; Kepp O; Menger L; Vacchelli E; Galluzzi L; Zitvogel L; Kroemer G
    Autophagy; 2012 Mar; 8(3):413-5. PubMed ID: 22361584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice.
    Michaud M; Martins I; Sukkurwala AQ; Adjemian S; Ma Y; Pellegatti P; Shen S; Kepp O; Scoazec M; Mignot G; Rello-Varona S; Tailler M; Menger L; Vacchelli E; Galluzzi L; Ghiringhelli F; di Virgilio F; Zitvogel L; Kroemer G
    Science; 2011 Dec; 334(6062):1573-7. PubMed ID: 22174255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective autophagy in vascular smooth muscle cells alters contractility and Ca²⁺ homeostasis in mice.
    Michiels CF; Fransen P; De Munck DG; De Meyer GR; Martinet W
    Am J Physiol Heart Circ Physiol; 2015 Mar; 308(6):H557-67. PubMed ID: 25576626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermal Delivery of Constructs Encoding Cre Recombinase to Induce Skin Tumors in Pten
    Deken MA; Song JY; Gadiot J; Bins AD; Kroon P; Verbrugge I; Blank CU
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy induction for the treatment of cancer.
    Pietrocola F; Pol J; Vacchelli E; Baracco EE; Levesque S; Castoldi F; Maiuri MC; Madeo F; Kroemer G
    Autophagy; 2016 Oct; 12(10):1962-1964. PubMed ID: 27532519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An inducible mouse model of melanoma expressing a defined tumor antigen.
    Huijbers IJ; Krimpenfort P; Chomez P; van der Valk MA; Song JY; Inderberg-Suso EM; Schmitt-Verhulst AM; Berns A; Van den Eynde BJ
    Cancer Res; 2006 Mar; 66(6):3278-86. PubMed ID: 16540681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective Autophagy in T Cells Impairs the Development of Diet-Induced Hepatic Steatosis and Atherosclerosis.
    Amersfoort J; Douna H; Schaftenaar FH; Foks AC; Kröner MJ; van Santbrink PJ; van Puijvelde GHM; Bot I; Kuiper J
    Front Immunol; 2018; 9():2937. PubMed ID: 30619297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Suppression Mediated by Myeloid and Lymphoid Derived Immune Cells in the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by Hras
    Jolly LA; Massoll N; Franco AT
    J Clin Cell Immunol; 2016 Oct; 7(5):. PubMed ID: 27942419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atg7 cooperates with Pten loss to drive prostate cancer tumor growth.
    Santanam U; Banach-Petrosky W; Abate-Shen C; Shen MM; White E; DiPaola RS
    Genes Dev; 2016 Feb; 30(4):399-407. PubMed ID: 26883359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth.
    Lévy J; Cacheux W; Bara MA; L'Hermitte A; Lepage P; Fraudeau M; Trentesaux C; Lemarchand J; Durand A; Crain AM; Marchiol C; Renault G; Dumont F; Letourneur F; Delacre M; Schmitt A; Terris B; Perret C; Chamaillard M; Couty JP; Romagnolo B
    Nat Cell Biol; 2015 Aug; 17(8):1062-73. PubMed ID: 26214133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition.
    Mok S; Tsoi J; Koya RC; Hu-Lieskovan S; West BL; Bollag G; Graeber TG; Ribas A
    BMC Cancer; 2015 May; 15():356. PubMed ID: 25939769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta activation promotes genetic context-dependent invasion of immortalized melanocytes.
    Lo RS; Witte ON
    Cancer Res; 2008 Jun; 68(11):4248-57. PubMed ID: 18519684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of autophagy ameliorates glucocorticoid-induced and ovariectomy-induced bone loss.
    Lin NY; Chen CW; Kagwiria R; Liang R; Beyer C; Distler A; Luther J; Engelke K; Schett G; Distler JH
    Ann Rheum Dis; 2016 Jun; 75(6):1203-10. PubMed ID: 26113650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells.
    Yang H; Yamazaki T; Pietrocola F; Zhou H; Zitvogel L; Ma Y; Kroemer G
    Cancer Res; 2015 Sep; 75(18):3812-22. PubMed ID: 26208907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells.
    Alissafi T; Hatzioannou A; Mintzas K; Barouni RM; Banos A; Sormendi S; Polyzos A; Xilouri M; Wielockx B; Gogas H; Verginis P
    J Clin Invest; 2018 Aug; 128(9):3840-3852. PubMed ID: 29920188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8
    Peng W; Williams LJ; Xu C; Melendez B; McKenzie JA; Chen Y; Jackson HL; Voo KS; Mbofung RM; Leahey SE; Wang J; Lizee G; Tawbi HA; Davies MA; Hoos A; Smothers J; Srinivasan R; Paul EM; Yanamandra N; Hwu P
    Clin Cancer Res; 2019 Nov; 25(21):6406-6416. PubMed ID: 31371342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic BRAF induces chronic ER stress condition resulting in increased basal autophagy and apoptotic resistance of cutaneous melanoma.
    Corazzari M; Rapino F; Ciccosanti F; Giglio P; Antonioli M; Conti B; Fimia GM; Lovat PE; Piacentini M
    Cell Death Differ; 2015 Jun; 22(6):946-58. PubMed ID: 25361077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells.
    Homet Moreno B; Zaretsky JM; Garcia-Diaz A; Tsoi J; Parisi G; Robert L; Meeth K; Ndoye A; Bosenberg M; Weeraratna AT; Graeber TG; Comin-Anduix B; Hu-Lieskovan S; Ribas A
    Cancer Immunol Res; 2016 Oct; 4(10):845-857. PubMed ID: 27589875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 361.